As the role of ARF as a tumor suppressor has been attributed majorly to MDM2 inhibition and subsequently p53 activation, further in-depth investigation is necessary to discover other downstream events responsible for the growth inhibition effect of ARF independently of p53 (Fig. 1). The gene discussed is TP53; the disease is neoplasm.